A study evaluating effect of rifampin on pharmacokinetics of ALKS-3831 in healthy human subjects.
Latest Information Update: 25 Mar 2019
At a glance
- Drugs Olanzapine/samidorphan (Primary) ; Rifampicin
- Indications Schizophrenia
- Focus Pharmacokinetics
- 19 Mar 2019 Results published in the Clinical Drug Investigation
- 28 Sep 2017 New trial record
- 01 Sep 2017 Results published in Clinical Pharmacology in Drug Development: 2017 Annual Meeting of the American College of Clinical Pharmacology